1,532 Followers on Owler
OverviewCompetitorsAcquisitionsInvestmentsNews & Insights

Merz Competitors or Alternatives

Merz's top competitors include Allergan, Galderma and Ipsen.

Unlock 18 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Merz's company profile

Philip Burchard

CEO

92/100
1,000 - 5,000
$0
$1B - 5B
  • $0
    $1B - 5B
  • 1,000 - 5,000
    $0
  • $1B - 5B
  • 92/100
  • 1,000 - 5,000
  • $0
  • $1B - 5B
View ProfileView
1
Merz's Competitor - Allergan logo

CEO

- -
10,000 - 50,000
$31.1M
$10B - 50B
  • $31.1M
    $10B - 50B
  • 10,000 - 50,000
    $31.1M
  • $10B - 50B
  • - -
  • 10,000 - 50,000
  • $31.1M
  • $10B - 50B
View ProfileView
2
Merz's Competitor - Galderma logo

Flemming Ornskov

CEO

66/100
6,500
$4.7B
$4.3B
  • $4.7B
    $4.3B
  • 6,500
    $4.7B
  • $4.3B
  • 66/100
  • 6,500
  • $4.7B
  • $4.3B
View ProfileView
3
Merz's Competitor - Ipsen logo

David Loew

CEO

94/100
5,358
$546.4M
$6.3B
  • $546.4M
    $6.3B
  • 5,358
    $546.4M
  • $6.3B
  • 94/100
  • 5,358
  • $546.4M
  • $6.3B
View ProfileView
4
Merz's Competitor - Teoxane logo

Valerie Taupin

Founder & CEO

86/100
250 - 500
- -
$5M - 25M
  • - -
    $5M - 25M
  • 250 - 500
    - -
  • $5M - 25M
  • 86/100
  • 250 - 500
  • - -
  • $5M - 25M
View ProfileView
5
Merz's Competitor - Revance logo

Mark J. Foley

President & CEO

81/100
500
$1.5B
$256.9M
  • $1.5B
    $256.9M
  • 500
    $1.5B
  • $256.9M
  • 81/100
  • 500
  • $1.5B
  • $256.9M
View ProfileView
Merz's top 21 competitors are Allergan, Galderma, Ipsen, Suneva Medical, Teoxane, Revance, Hikma, Theravance Biopharma, Aclaris, Genentech, Roche, AstraZeneca, Novartis, Sanofi, Amgen, GSK, Bristol-Myers Squibb, Bayer , Biogen, Celgene and Gilead. Together they have raised over 55.8B between their estimated 668.9K employees. Merz's revenue is the ranked 17th among it's top 10 competitors. The top 10 competitors average 23.4B. Merz has 3,000 employees and is ranked 17th among it's top 10 competitors. The top 10 competitors average 30,541.

Merz VS Allergan

Allergan is Merz's #1 competitor. Allergan is a Private company that was founded in 1948 in Coolock, County Dublin. Allergan is in the Pharmaceuticals industry. Compared to Merz, Allergan has 13,900 more employees.

Merz VS Galderma

Galderma is seen as one of Merz's biggest rivals. Galderma was founded in Zug, Zug} in 1981. Galderma is in the Health Care Supplies field. Compared to Merz, Galderma generates $2.7B more revenue.

Merz VS Ipsen

Ipsen is one of Merz's top competitors. Ipsen is headquartered in Boulogne-Billancourt, Île-de-France, and was founded in 1929. Ipsen competes in the Pharmaceuticals industry. Ipsen generates 390% the revenue of Merz.

Looking for similar companies to Merz?

Similar Companies

Companies in Frankfurt with revenue in $1.0-5.0B range

See 11 companies 
Companies in Hesse with revenue in $1.0-5.0B range

See 42 companies 
Companies in Frankfurt with employees in 1.0-5.0K range

See 22 companies 
Companies in Hesse with employees in 1.0-5.0K range

See 79 companies 
Pharmaceuticals companies in Hesse

See 82 companies 
Pharmaceuticals & Biotechnology companies in Hesse

See 117 companies 
Pharmaceuticals companies with revenue in $1.0-5.0B range

See 144 companies 
Pharmaceuticals & Biotechnology companies with revenue in $1.0-5.0B range

See 195 companies 
Pharmaceuticals companies with employees in 1.0-5.0K range

See 203 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Merz and Merz's Competitors

April 5, 2025Pharmabiz
AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of ad...
April 7, 2025Pharmaceutical Business Review
This decision is based on the randomised MITIGATE trial data, which showed the antibody's potential to reduce disease activity by minimising flares in ...
April 7, 2025Biospectrum Asia
GSK signs £2 B deal with Korean startup ABL Bio for treatment of neurodegenerative diseases...
April 7, 2025Endpoints News
South Korean biotech ABL Bio has lined up another platform license agreement with a European pharma giant in the area of neurodegenerative diseases. AB...
April 5, 2025Pharmabiz
AstraZeneca's Imfinzi (durvalumab) in combination with chemotherapy has been approved in the European Union (EU) for the treatment of adults with resec...
April 5, 2025Benzinga
NEW YORK, April 05, 2025 (GLOBE NEWSWIRE) --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ...
April 7, 2025KED Global
ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called the Grabody-B, to UK-based ...
April 7, 2025Openpr
The bronchial spasm market is estimated to be valued at USD 14.1 Bn in 2024 and is expected to reach USD 21.7 Bn by 2031, growing at a compound annual ...
April 7, 2025Mychesco
WILMINGTON, DE - AstraZeneca 's IMFINZI® (durvalumab) has gained FDA approval for use in adult patients with muscle-invasive bladder cancer (MIBC), mak...
April 7, 2025Openpr
The Global Necrotising Enterocolitis Market is estimated to be valued at USD 7.10 Billion in 2024 and is expected to reach USD 10.41 Billion by 2031, g...

Frequently Asked Questions about Merz

  1. Who are Merz's top competitors?

    Merz's top 3 competitors are Allergan, Galderma, Ipsen.

  2. Who is similar to Merz?

    Allergan is the most similar to Merz. Galderma and Ipsen are also similar to Merz.

  1. Are Merz and Allergan competitors?

    Yes, Allergan is one of Merz’s top competitors.